Evidence map›Paper›PMID 32082997›Full record

ArticleFrontiers in oncology2020

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.

Duo Hong, Ke Xu, Lina Zhang, Xiaoting Wan, Yan Guo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. PredictingTranslational lung cancer research · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Detection ofTranslational cancer research · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Duo HongDepartment of Radiology, The First Hospital of China Medical University, Shenyang, China.
Ke XuDepartment of Radiology, The First Hospital of China Medical University, Shenyang, China.
Lina ZhangDepartment of Radiology, The First Hospital of China Medical University, Shenyang, China.
Xiaoting WanDepartment of Radiology, The First Hospital of China Medical University, Shenyang, China.
Yan GuoGE Healthcare, Shanghai, China.
First Hospital of China Medical University · CNChina Medical University · CNUnited Imaging Healthcare (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced lung adenocarcinomaepidermal growth factor receptormutationradiomicstomography

Identifiers

PMID32082997
PMCPMC7005234
OpenAlexW3003975456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.